© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 18, 1522-1528,
September 20, 2000
© 2000 Oxford University Press
REPORTS |
Risk of Hodgkin's Disease and Other Cancers After Infectious Mononucleosis
Affiliations of authors: H. Hjalgrim, P. Sørensen, M. Frisch, M. Melbye, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; J. Askling, A. Ekbom, Department of Medical Epidemiology, Karolinska Institute, Stockholm, Sweden; M. Madsen, L. S. Eriksen, The Danish Institute for Clinical Epidemiology, Copenhagen; N. Rosdahl, Medical Office of Health, City of Copenhagen; H. H. Storm, Institute of Cancer Epidemiology, The Danish Cancer Society, Copenhagen; S. Hamilton-Dutoit, Institute of Pathology, Aarhus University Hospital, Denmark.
Correspondence to: Henrik Hjalgrim, M.D., Department of Epidemiology Research, Statens Serum Institut, 5 Artillerivej, DK-2300 Copenhagen S, Denmark (e-mail: hhj{at}ssi.dk).
Background: Infectious mononucleosis, which is caused by the Epstein-Barr virus, has been associated with an increased risk for Hodgkin's disease. Little is known, however, about how infectious mononucleosis affects long-term risk of Hodgkin's disease, how this risk varies with age at infectious mononucleosis diagnosis, or how the risk for Hodgkin's disease varies in different age groups. In addition, the general cancer profile among patients who have had infectious mononucleosis has been sparsely studied. Methods: Population-based cohorts of infectious mononucleosis patients in Denmark and Sweden were followed for cancer occurrence. The ratio of observed-to-expected numbers of cancers (standardized incidence ratio [SIR]) served as a measure of the relative risk for cancer. SIRs of Hodgkin's disease in different subsets of patients were compared with the use of Poisson regression analysis. All statistical tests including the trend tests were two-sided. Results: A total of 1381 cancers were observed during 689 619 person-years of follow-up among 38 562 infectious mononucleosis patients (SIR = 1.03; 95% confidence interval [CI] = 0.98–1.09). Apart from Hodgkin's disease (SIR = 2.55; 95% CI = 1.87–3.40; n = 46), only skin cancers (SIR = 1.27; 95% CI = 1.13–1.43; n = 291) occurred in statistically significant excess. In contrast, the SIR for lung cancer was reduced (SIR = 0.71; 95% CI = 0.58–0.86; n = 102). The SIR for Hodgkin's disease remained elevated for up to two decades after the occurrence of infectious mononucleosis but decreased with time since diagnosis of infectious mononucleosis (P for trend <.001). The SIR for Hodgkin's disease tended to increase with age at diagnosis of infectious mononucleosis (P for trend = .05). Following infectious mononucleosis, the SIR for Hodgkin's disease at ages 15–34 years was 3.49 (95% CI = 2.46–4.81; n = 37), which was statistically significantly higher than the SIR for any other age group (P for difference = .001). Conclusion: The increased risk of Hodgkin's disease after the occurrence of infectious mononucleosis appears to be a specific phenomenon.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Hjalgrim, K. Ekstrom Smedby, K. Rostgaard, D. Molin, S. Hamilton-Dutoit, E. T. Chang, E. Ralfkiaer, C. Sundstrom, H.-O. Adami, B. Glimelius, et al. Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma Cancer Res., March 1, 2007; 67(5): 2382 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Chang, T. Zheng, E. G. Weir, M. Borowitz, R. B. Mann, D. Spiegelman, and N. E. Mueller Childhood Social Environment and Hodgkin's Lymphoma: New Findings from a Population-Based Case-Control Study Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1361 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Chang, S. M. Montgomery, L. Richiardi, A. Ehlin, A. Ekbom, and M. Lambe Number of Siblings and Risk of Hodgkin's Lymphoma Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1236 - 1243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hjalgrim, S. Rasmussen, K. Rostgaard, N. M. Nielsen, N. Koch-Henriksen, L. Munksgaard, H. H. Storm, and M. Melbye Familial Clustering of Hodgkin Lymphoma and Multiple Sclerosis J Natl Cancer Inst, May 19, 2004; 96(10): 780 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Cozen, P. S. Gill, S. A. Ingles, R. Masood, O. Martinez-Maza, M. G. Cockburn, W. J. Gauderman, M. C. Pike, L. Bernstein, B. N. Nathwani, et al. IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma Blood, April 15, 2004; 103(8): 3216 - 3221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hjalgrim, J. Askling, K. Rostgaard, S. Hamilton-Dutoit, M. Frisch, J.-S. Zhang, M. Madsen, N. Rosdahl, H. B. Konradsen, H. H. Storm, et al. Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis N. Engl. J. Med., October 2, 2003; 349(14): 1324 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Krieger, E. F. Strong, C. Makosky, and J. Weuve Breast Cancer, Birth Cohorts, and Epstein-Barr Virus: Methodological Issues in Exploring the "Hygiene Hypothesis" in Relation to Breast Cancer, Hodgkin's Disease, and Stomach Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 405 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Glaser Correspondence re: Yasui et al., Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection. 10: 9-16, 2001 Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 73 - 73. [Full Text] [PDF]
|
|
|
|
|
|
H. Hjalgrim, K. Rostgaard, J. Askling, M. Madsen, H. H. Storm, C. S. Rabkin, and M. Melbye Hematopoietic and Lymphatic Cancers in Relatives of Patients With Infectious Mononucleosis J Natl Cancer Inst, May 1, 2002; 94(9): 678 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Alexander, R. F. Jarrett, R. A. Cartwright, A. A. Armstrong, D. A. Gokhale, E. Kane, D. Gray, D. J. Lawrence, and G. M. Taylor Epstein-Barr Virus and HLA-DPB1-*0301 in Young Adult Hodgkin's Disease: Evidence for Inherited Susceptibility to Epstein-Barr Virus in Cases that Are EBV+ve Cancer Epidemiol. Biomarkers Prev., June 1, 2001; 10(6): 705 - 709. [Abstract] [Full Text] [PDF]
|
|